On the Way to the Optimal Bioprocess
August 10, 2020
1 Min Read
Sponsored by Zeta Pharmaceuticals
Countless factors influence a bioprocess, and measuring and evaluating them can be a major challenge. One of the most important performance parameters is the volumetric mass-transfer coefficient (kLa). ZETA has developed a reliable method for determining the kLa value and thus has revolutionized bioreactor design in plant engineering. With ZETA’s mass-transfer coefficient value determination system, measurements to determine kLa value can be taken at any point in a bioreactor, and based on such measurements, production conditions can be mapped perfectly.
Fill out the form below to read the complete technology review now.
Andelyn to make viral vectors in FDA-NIH led gene therapy consortium
Mar 1, 2024|1 Min ReadGLP-1 drug demand drives $250m fill/finish expansion for Simtra
Mar 1, 2024|3 Min ReadAstraZeneca to build global strategic center in Shanghai
Mar 1, 2024|3 Min ReadIns & Outs: Gonzalez but not forgotten at AbbVie
Feb 29, 2024|2 Min ReadMar 11 - Mar 14, 2024
Mar 11 - Mar 14, 2024
Accelerate speed to market for your next generation mAbs, vaccines, cell therapy, and gene therapy products. At the BioProcess International US West event in San Diego, CA, in March 2024 you can access today's innovative strategies and technologies designed to improve process efficiencies and maintain product quality across all phases of bioprocessing.